SPOTLIGHT -
The FDA has approved a new drug application by ISTA Pharmaceuticals for the once-daily liquid formulation of timolol 0.5% as a therapy for glaucoma.
Ocuphire Pharma’s ZETA-1 phase 2 trial of diabetic retinopathy candidate offers mixed results
Commercial real estate and your practice, part two with Colin Carr
UT Southwestern ophthalmologist shares techniques for cataract surgery complications
Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)
ARVO announces recipients of 2023 Pfizer Ophthalmics Carl Camras Translational Research Award
Expanding gene therapy for Usher Syndrome Type 2A